DJIA 17,678.70 6.10 0.03%
NASDAQ 4,771.76 13.88 0.29%
S&P 500 2,057.09 5.27 0.26%
market minute promo

56.56 1.89 (3.46%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LGND $56.56 3.46%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $54.48
Previous Close $54.67
Daily Range $54.28 - $56.65
52-Week Range $41.99 - $80.42
Market Cap $1.1B
P/E Ratio 165.67
Dividend (Yield) $0.00 (0.0%)
Volume 233,461
Average Daily Volume 245,593
Current FY EPS $0.98

Sector

Healthcare

Industry

Drugs

Ligand Pharmaceuticals, Inc. (LGND) Description

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases. Website: http://www.ligand.com/

News & Commentary Rss Feed

3 Stocks That Soared Stupendously This Week

Double-digit gains in a shortened trading week? Here's how these 3 stocks did it.

Ligand Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for LGND

Update: Ligand Partner Moves Closer To Delafloxacin Launch

Insider Trading Alert - NWE, PF And LGND Traded By Insiders

LGND: Insiders Vs. Shorts

Spectrum Is An Interesting Biotechnology Investment

Spectrum/Ligand Pharma Seek FDA Nod for CE-Melphalan - Analyst Blog

Update: Ligand Announces Key Regulatory Submissions

Spectrum submits blood-cancer drug for FDA approval

Update: Ligand Wins EU Approval For Duavive

UPDATE: Deutsche Bank Initiates Coverage On Ligand Pharmaceuticals On Growing Royalty Play On Biopha

UPDATE: Deutsche Bank Initiates Coverage On Ligand Pharmaceuticals On Growing Royalty Play On Biopharma

See More LGND News...

LGND's Top Competitors

LGND $56.56 (3.46%)
Current stock: LGND
AMGN $159.73 (-0.05%)
Current stock: AMGN
GILD $107.12 (1.50%)
Current stock: GILD
BIIB $362.44 (1.37%)
Current stock: BIIB